Evidence map›Paper›PMID 31815530›Full record

ArticleAIDS education and prevention : official publication of the International Society for AIDS Education2019

Mapping the Study Characteristics and Topics of HIV Pre-Exposure Prophylaxis Research Literature: A Scoping Review.

Emiko Kamitani, Yuko Mizuno, Megan Wichser, Adebukola H Adegbite, Julia B DeLuca, Darrel H Higa

Abstract readScoping Review
In one paragraph

Article in AIDS education and prevention : official publication of the International Society for AIDS Education, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Emiko KamitaniCenters for Disease Control and Prevention, Atlanta, Georgia.
Yuko MizunoCenters for Disease Control and Prevention, Atlanta, Georgia.
Megan WichserCenters for Disease Control and Prevention, Atlanta, Georgia.
Adebukola H AdegbiteCenters for Disease Control and Prevention, Atlanta, Georgia.
Julia B DeLucaCenters for Disease Control and Prevention, Atlanta, Georgia.
Darrel H HigaCenters for Disease Control and Prevention, Atlanta, Georgia.

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

Since WHO released the first PrEP guidance in 2012, the PrEP research literature has rapidly increased, but PrEP uptake is still low. To identify research gaps, this scoping review describes study characteristics, identifies populations, and maps study topics in PrEP publications. We identified 561 PrEP primary studies published in English between 2006 and 2018. The most commonly used study design was cross-sectional. Almost half of studies were conducted in non-U.S. countries and focused on men who have sex with men. We mapped study topics using five categories. The most studied category was Potential PrEP user/prescriber (41.3%) followed by Considerations while on PrEP (28.2%), PrEP efficacy and safety (20.9%), Cost-effectiveness or economic evaluation (5.2%), and Methods of and experiences with PrEP clinical trials (4.2%). Although the PrEP literature has dramatically increased, some research areas (e.g., PrEP awareness in non-U.S. countries, intervention studies to promote PrEP use) and populations (e.g., Black women) are still understudied.

Indexed as

Pre-Exposure ProphylaxisAdultAnti-HIV AgentsAwarenessCost-Benefit AnalysisFemaleHealth Knowledge, Attitudes, PracticeHIV InfectionsHumansMaleMiddle AgedSex FactorsSexual BehaviorAnti-HIV AgentsHIVpre-exposure prophylaxisresearch disparityscoping review

Identifiers

PMID31815530
PMCPMC8022292

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.